Walleye Capital’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$22 Sell
11
-291
-96% -$805 ﹤0.01% 5903
2026
Q2
$782 Sell
302
-96
-24% -$284 ﹤0.01% 4612
2026
Q1
$1.22K Sell
398
-5,611
-93% -$24.3K ﹤0.01% 4257
2025
Q4
$21.4K Buy
+6,009
New +$36.8K ﹤0.01% 4239

Other funds holding AVXL

Walleye Capital's AVXL Position: Q3 2026 in Review

Walleye Capital reduced its Anavex Life Sciences (AVXL) stake by 96% in Q3 2026, selling an estimated $805 and leaving 11 shares worth $22. The position accounts for ﹤0.01% of the portfolio, ranked #5903.

Walleye Capital first reported a position in AVXL in Q4 2025 and has held it in 4 quarters since. The position peaked at $21.4K in Q4 2025. 164 funds tracked by Wall St. Rank hold AVXL as of Q3 2026.

  • Walleye Capital held 11 shares of Anavex Life Sciences worth $22 as of Q3 2026.
  • Walleye Capital sold 291 Anavex Life Sciences shares in Q3 2026, an estimated $805.
  • Anavex Life Sciences made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #5903 holding.
  • Walleye Capital first reported a position in Anavex Life Sciences in Q4 2025 and has held it in 4 quarters since.
  • Walleye Capital's Anavex Life Sciences position peaked at $21.4K in Q4 2025.
  • 164 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.